BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31759867)

  • 41. ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
    Jirsa M; Bronský J; Dvořáková L; Šperl J; Šmajstrla V; Horák J; Nevoral J; Hřebíček M
    World J Gastroenterol; 2014 May; 20(19):5867-74. PubMed ID: 24914347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Childhood cholestasis and bile transporters].
    Hierro L; Jara P
    Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
    Oude Elferink RP; Paulusma CC
    Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
    Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
    J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
    Sticova E; Jirsa M; Pawłowska J
    Can J Gastroenterol Hepatol; 2018; 2018():2313675. PubMed ID: 30148122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
    De Masi R; Orlando S; De Donno A
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2347-2350. PubMed ID: 31568708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paucity of Interlobular Bile Ducts in Multidrug-Resistant P-Glycoprotein 3 (MDR3) Deficiency.
    Vij M; Valamparampil J; Shanmugum N; Reddy SM; Rajindrajith S; Rela M
    Int J Surg Pathol; 2019 May; 27(3):343-347. PubMed ID: 30222019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Meier PJ; Stieger B
    Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Liver disease associated with hereditary defects of hepatobiliary transporters].
    Wendum D
    Ann Pathol; 2010 Dec; 30(6):426-31. PubMed ID: 21167428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
    Wu Z; Zhang S; Zhang L; Li M
    Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current and future therapies for inherited cholestatic liver diseases.
    van der Woerd WL; Houwen RH; van de Graaf SF
    World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
    Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
    J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Analysis of
    Wang HH; Portincasa P; Liu M; Wang DQ
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.
    Anzivino C; Odoardi MR; Meschiari E; Baldelli E; Facchinetti F; Neri I; Ruggiero G; Zampino R; Bertolotti M; Loria P; Carulli L
    Dig Liver Dis; 2013 Mar; 45(3):226-32. PubMed ID: 23022423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
    Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
    Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
    Fein F; Hermelin B; Becker MC; Felix S; Carbonnel F
    Gastroenterol Clin Biol; 2007 Jan; 31(1):106-9. PubMed ID: 17273143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.